Voloridge Investment Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Voloridge Investment Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-21,387	Closed	-$806K	–	1875
2021 Q1	$806K	Buy	+21,387	New	+$533K	0.01%	1085

Voloridge Investment Management's FPRX Position: Q2 2021 in Review

Voloridge Investment Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 21,387 shares — an estimated $806K sold.

Voloridge Investment Management first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $806K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Voloridge Investment Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Voloridge Investment Management sold 21,387 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $806K.
Voloridge Investment Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
Voloridge Investment Management's Five Prime Therapeutics, Inc. position peaked at $806K in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Voloridge Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.